PRKDC and cancer: Interestingly, genetic and pharmacological targeting of a strong non-oncogene addiction to DNA-PKcs (DNA-dependent protein kinase catalytic subunit) leads to the accumulation of DNA double-strand breaks in ATM-defective cancer cells, which triggers cell apoptosis via the proapoptotic signaling pathway [91].